Scoliosis Treatment Market: Increasing Prevalence Rate of Scoliosis Coupled with an Increasing Demand for Spine Surgeries is Projected to Boost the Market Growth at a Healthy CAGR of 3.9% During the Forecast Period of 2019 to 2025

Pune, India, August 2019/MRFR Press Release/- Market Research Future has published its Half-Cooked Research Report on the Global Scoliosis Treatment Market.

Market Highlights

It is estimated that the global scoliosis treatment market is expected to register a CAGR of~ 3.9% during the forecast period of 2019 to 2025, with a market value of USD 2,580.2 million in 2018. Scoliosis causes the spine to curve to one side and can affect any part of the spine, but the most commonly affected areas are at the level of the chest and the lower back. The scoliosis treatment market is driven by various factors such as the increasing prevalence of scoliosis surgeries, increasing demand for spine surgeries, the high adoption rate of braces, and the growing prevalence of musculoskeletal disorders. However, the high cost of treatment or procedures and limited understanding of the disorder and available treatment options are expected to curb the growth of the scoliosis treatment market. The global scoliosis treatment market is currently dominated by numerous market players. The key players are involved in product launches and strategic collaborations to strengthen its market position. For instance, in July 2018, NuVasive Launched MAGEC X for early-onset scoliosis treatment. The latest advancement of MAGEC delivers improved rod strength together with internal rod mechanism advancements.

Regional Analysis

Based on region, the market can be divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The scoliosis treatment market in the Americas has further been segmented into Latin America and North America, with the North American market further sub-segmented into the US and Canada. The European scoliosis treatment market has been sub-divided Western Europe and Eastern Europe. Western Europe has further been divided as France, Germany, the UK, Spain, Italy, and the rest of Western Europe. The scoliosis treatment market in Asia-Pacific has been bifurcated into Australia, China, Japan, India, South Korea, and the rest of Asia-Pacific. The scoliosis treatment market in the Middle East & Africa has been segmented into the Middle East and Africa.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/scoliosis-treatment-market-8230

Segmentation

The global scoliosis treatment market has been segmented based on disease, product and distribution channel. The market, based on disease, has been further divided into infantile idiopathic scoliosis and adolescent idiopathic scoliosis. The adolescent idiopathic scoliosis segment is likely to hold a major share in the market due to the increasing prevalence of scoliosis in the adults majorly. The product segment has been segmented into cervical thoracic lumbar sacral orthosis (CTLSO), thoracolumbosacral orthosis (TLSO), and lumbosacral orthosis (LSO). The cervical thoracic lumbar sacral orthosis (CTLSO) is predicted to be the fastest-growing due to increasing demand for spine surgeries. The distribution channel segment has been categorized as hospitals & clinics, retail pharmacies, and online pharmacies.

Key Players

Some of the key players in the global scoliosis treatment market are NuVasive, Spinal Technology, Inc., C H Martin Company, Aspen Medical Products, Lawall Prosthetics and Orthotics, SPINEFORM LLC, Össur, Orthotech, Chaneco, Boston Orthotics & Prosthetics, Charleston Bending Brace, Trulife, DJO, Wilmington Orthotics & Prosthetics, Inc., Horton's Orthotics & Prosthetics, UNYQ, Optec USA, Inc., and Zimmer Biomet Holdings Inc.